Marijuana Compounds: A Nonconventional Approach to Parkinson's Disease Therapy.

Citation data:

Parkinson's disease, ISSN: 2090-8083, Vol: 2016, Page: 1279042

Publication Year:
2016
Usage 5552
Abstract Views 3206
Full Text Views 2000
Link-outs 277
Downloads 69
Captures 430
Exports-Saves 375
Readers 55
Mentions 1
Blog Mentions 1
Social Media 95
Shares, Likes & Comments 77
Tweets 18
Citations 2
Citation Indexes 2
Repository URL:
https://touroscholar.touro.edu/tcopny_pubs/31; https://touroscholar.touro.edu/cgi/viewcontent.cgi?article=1030&context=tcopny_pubs; https://doi.org/10.1155/2016/1279042
PMID:
28050308
DOI:
10.1155/2016/1279042
PMCID:
PMC5165161
Author(s):
Babayeva, Mariana; Assefa, Haregewein; Basu, Paramita; Chumki, Sanjeda; Loewy, Zvi G.
Publisher(s):
Hindawi Limited; Touro Scholar; Parkinson’s Disease
Tags:
Neuroscience; Medicine; medical marijuana; Parkinson's disease; treatment; cannabis; Nervous System Diseases; Therapeutics
Most Recent Tweet View All Tweets
Most Recent Blog Mention
review description
Parkinson's disease (PD), a neurodegenerative disorder, is the second most common neurological illness in United States. Neurologically, it is characterized by the selective degeneration of a unique population of cells, the nigrostriatal dopamine neurons. The current treatment is symptomatic and mainly involves replacement of dopamine deficiency. This therapy improves only motor symptoms of Parkinson's disease and is associated with a number of adverse effects including dyskinesia. Therefore, there is unmet need for more comprehensive approach in the management of PD. Cannabis and related compounds have created significant research interest as a promising therapy in neurodegenerative and movement disorders. In this review we examine the potential benefits of medical marijuana and related compounds in the treatment of both motor and nonmotor symptoms as well as in slowing the progression of the disease. The potential for cannabis to enhance the quality of life of Parkinson's patients is explored.